Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levels.

导出 OA

翻译打印收藏纠错

作者： Gorkem,Kismali ^[1] ; Ganiraju,Manyam ^[2] ; Nitin,Jain ^[3] ; Cristina,Ivan ^[4] ; Betty,Lamothe ^[5] ; Mary L,Ayres ^[6] ; LaKesla R,Iles ^[6] ; William G,Wierda ^[3] ; Varsha,Gandhi ^[7]

作者单位： Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Ankara University Faculty of Veterinary Medicine, Department of Biochemistry, Ankara, Turkey. ^[1] Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[3] Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Caris Life Sciences, Irving, TX, USA. ^[4] Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Incyte Pharmaceuticals, Wilmington, Delaware, USA. ^[5] Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[6] Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vgandhi@mdanderson.org.;Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vgandhi@mdanderson.org. ^[7]